Provided by Tiger Trade Technology Pte. Ltd.

CNS Pharmaceuticals, Inc.

5.32
+0.08451.61%
Post-market: 5.320.00000.00%19:30 EDT
Volume:10.90K
Turnover:57.59K
Market Cap:7.78M
PE:-0.23
High:5.40
Open:5.23
Low:5.11
Close:5.24
52wk High:10.59
52wk Low:1.90
Shares:1.46M
Float Shares:1.35M
Volume Ratio:4.17
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-23.1416
EPS(LYR):-35.7503
ROE:-106.62%
ROA:-58.01%
PB:0.43
PE(LYR):-0.15

Loading ...

Jul 28, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Major Issues Report

8-K - Current report
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2022

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2022

Major Issues Report

8-K - Current report
Feb 18, 2022

Major Issues Report

8-K - Current report
Jan 28, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jan 10, 2022

Major Issues Report

8-K - Current report
Jan 06, 2022

Major Issues Report

8-K - Current report
Dec 07, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 16, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 16, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 01, 2021

Major Issues Report

8-K - Current report
May 18, 2021

Major Issues Report

8-K - Current report
May 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 17, 2021

Major Issues Report

8-K - Current report